GSK has announced that in spite of significant increases in supply of Bexsero (meningococcal B) vaccine this year, it still isn't meeting demand and it is working hard to bring more doses into the country.
The company is bringing an additional 200,000 doses of Bexsero into Australia and they will be available from pharmacies and GP surgeries from the start of Jun.
"We understand it has been distressing for parents who want to protect their children against meningococcal B but haven't been able to access the vaccine," a GSK spokesperson said.
"We hope these additional doses will go along way to meet the current demand."
Families can expect to pay in the range of $120-140 per dose of Bexsero depending on which pharmacy they visit.
More info from GSK medical information on 1800 033 109.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 17
